Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett

Showing results (831-840 of 908) with videos related to

Pageof 91
Sort By:
Bone Research|July 25, 2022
Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153Yi-Nan Li, Chih-Wei Chen, Thuong Trinh-Minh, et al.
Annals of the Rheumatic Diseases|July 29, 2020
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imagingChristian Schmidkonz, Simon Rauber, Armin Atzinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2021
Overexpression of Transmembrane TNF Drives Development of Ectopic Lymphoid Structures in the Bone Marrow and B Cell Lineage Alterations in Experimental SpondyloarthritisMerlijn H Kaaij, Jasper Rip, Kim C M Jeucken, et al.
Immunity|October 13, 2021
IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammationMaria Faas, Natacha Ipseiz, Jochen Ackermann, et al.
Arthritis Research & Therapy|April 14, 2021
Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trialJohannes Knitza, Jacob Mohn, Christina Bergmann, et al.
Annals of the Rheumatic Diseases|February 10, 2015
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO studyJudith Haschka, Matthias Englbrecht, Axel J Hueber, et al.
Annals of the Rheumatic Diseases|June 2, 2011
Animal models for arthritis: innovative tools for prevention and treatmentGeorge Kollias, Piyi Papadaki, Florence Apparailly, et al.
Nature Metabolism|March 20, 2019
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signalingMartina Rauner, Ulrike Baschant, Antonella Roetto, et al.
The Lancet. Rheumatology|May 3, 2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational studyMelanie Hagen, Fabian Müller, Andreas Wirsching, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 20, 2025
Incidence, characteristics and consequences of fractures after acute ischemic stroke and TIA - a prospective cohort studyAnel Karisik, Benjamin Dejakum, Kurt Moelgg, et al.
Pageof 91

Showing results (831-840 of 908) with videos related to

Sort By:
Pageof 91
Bone Research|July 25, 2022
Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153Yi-Nan Li, Chih-Wei Chen, Thuong Trinh-Minh, et al.
Annals of the Rheumatic Diseases|July 29, 2020
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imagingChristian Schmidkonz, Simon Rauber, Armin Atzinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2021
Overexpression of Transmembrane TNF Drives Development of Ectopic Lymphoid Structures in the Bone Marrow and B Cell Lineage Alterations in Experimental SpondyloarthritisMerlijn H Kaaij, Jasper Rip, Kim C M Jeucken, et al.
Immunity|October 13, 2021
IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammationMaria Faas, Natacha Ipseiz, Jochen Ackermann, et al.
Arthritis Research & Therapy|April 14, 2021
Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trialJohannes Knitza, Jacob Mohn, Christina Bergmann, et al.
Annals of the Rheumatic Diseases|February 10, 2015
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO studyJudith Haschka, Matthias Englbrecht, Axel J Hueber, et al.
Annals of the Rheumatic Diseases|June 2, 2011
Animal models for arthritis: innovative tools for prevention and treatmentGeorge Kollias, Piyi Papadaki, Florence Apparailly, et al.
Nature Metabolism|March 20, 2019
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signalingMartina Rauner, Ulrike Baschant, Antonella Roetto, et al.
The Lancet. Rheumatology|May 3, 2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational studyMelanie Hagen, Fabian Müller, Andreas Wirsching, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 20, 2025
Incidence, characteristics and consequences of fractures after acute ischemic stroke and TIA - a prospective cohort studyAnel Karisik, Benjamin Dejakum, Kurt Moelgg, et al.
Pageof 91